NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2024. All Rights Reserved.
Date: Thursday, March 28, 2024 17:25

Description: MSD-AH
Release 2.45
Panacur® Small Animal 2.5% oral suspension
 
Species: Cats, Dogs
Therapeutic indication: Pharmaceuticals: Endoparasiticides: Anthelmintics for dogs, Anthelmintics for cats
Active ingredient: Fenbendazole
Product:Panacur® Small Animal 2.5% oral suspension
Product index: Panacur® Small Animal 2.5%
Incorporating:
Qualitative and quantitative composition
Active substance % w/v
Fenbendazole 2.500
Other substances
Sodium methyl hydroxybenzoate 0.200
Sodium propyl hydroxybenzoate 0.0216
Benzyl alcohol 0.4835
For the full list of excipients, see section “Pharmaceutical particulars”.
Pharmaceutical form
A white, practically odourless, oral suspension.
Clinical particulars
Target Species
Domestic dogs, cats, puppies and kittens.
Indications for use
A broad spectrum anthelmintic for the treatment of domestic dogs and cats infected with immature and mature stages of nematodes of the gastro-intestinal and respiratory tracts.
Adult dogs and cats: For the treatment of adult dogs and cats infected with gastro-intestinal nematodes and cestodes:
Ascarid spp. (Toxocara canis, Toxocara cati , Toxascaris leonina)
Ancylostoma spp.
Trichuris spp.
Uncinaria spp.
Taenia spp.
Puppies and kittens: For the treatment of puppies and kittens infected with gastro-intestinal nematodes and puppies infected with protozoa (Giardia spp.).
Pregnant dogs: For the treatment of pregnant dogs to reduce prenatal infections with Toxocara canis and the transfer of T.canis and Ancylostoma caninum to their pups via the milk.
Also for the treatment of domestic dogs infected with lungworm Oslerus (Filaroides) osleri or protozoa Giardia spp., and cats infected with lungworm Aelurostrongylus abstrusus.
Also has an ovicidal effect on nematode eggs.
Contraindications
None known.
Special warnings for each target species
None.
Special precautions for use
Assess bodyweight as accurately as possible before calculating the dosage.
Operator warnings
Direct contact with the skin should be kept to a minimum.
Wear impermeable rubber gloves and wash hands after use.
Adverse Reactions
None known.
Use during pregnancy or lactation
The product can be safely administered to pregnant females.
Interactions
None known.
Amounts to be administered and administration route
Shake container before use.
Routine treatment of adult dogs and cats
4 ml per 1 kg bodyweight as a single oral dose.
(= 100 mg fenbendazole/kg bodyweight)
The dose should be added to feed, directly before feeding or administered by mouth directly after feeding.
Treatment should be repeated when natural re-infestation with parasitic worms occurs. Routine treatment of adult animals with minimal exposure to infection is advisable 2 to 4 times per year.
More frequent treatment at 6 and 8 weekly intervals is advisable for dogs in kennels.
Puppies and kittens under six months of age
2 ml per kg bodyweight daily for 3 consecutive days given by mouth directly after feeding to unweaned animals or added to feed for weaned animals, directly before feeding.
(= 50 mg fenbendazole/kg bodyweight daily for 3 days)
Practical dosage recommendations:
250 g 0.5 ml daily for 3 days
500 g 1 ml daily for 3 days
1 kg 2 ml daily for 3 days
1.5 kg 3 ml daily for 3 days
2 kg 4 ml daily for 3 days
For puppies weighing over 2 kg, an extra 2 ml is required daily for each additional kg bodyweight.
Puppies should be treated at 2 weeks of age, 5 weeks of age and again before leaving the breeder's premises. Treatment may also be required at 8 and 12 weeks of age. Thereafter, frequency of treatment can be reduced unless the pups remain in kennels where reinfestation occurs more readily.
Pregnant dogs
1 ml per 1 kg bodyweight daily from day 40 of pregnancy continuously to 2 days post-whelping (approximately 25 days)
(= 25 mg fenbendazole/kg bodyweight daily)
Practical dosage recommendations:
2 to 4 kg 4 ml daily for approx. 25 days
4 to 8 kg 8 ml daily for approx. 25 days
8 to 16 kg 16 ml daily for approx. 25 days
As treatment of pregnant dogs is 98% effective, puppies from these dogs should themselves be treated with a 3 day course at 2 and 5 weeks of age.
Pregnant cats
Pregnant cats can be safely treated but only require a single treatment at the routine adult dose rate. Administer 4ml per kg bodyweight as a single dose.
(=100mg fenbendazole/kg bodyweight)
Increased dosing for specific infections:
For the treatment of clinical worm infestations in adult dogs and cats or Giardia spp infections in dogs, administer 2 ml per kg bodyweight daily for 3 consecutive days.
(= 50 mg fenbendazole/kg bodyweight daily for 3 days)
For the control of lungworm Oslerus (Filaroides) osleri in dogs administer
2 ml per kg bodyweight, daily for 7 consecutive days.
(= 50 mg fenbendazole/kg bodyweight daily for 7 days)
A repeat course of treatment may be required in some cases.
For the control of lungworm Aelurostrongylus abstrusus in cats administer 2 ml per kg bodyweight daily for 3 consecutive days.
(=50 mg fenbendazole/kg bodyweight daily for 3 days)
Overdose
Benzimidazoles have a high margin of safety.
Withdrawal periods
Not applicable.
Pharmacological particulars
ATC Vet Code QP52AC13
Pharmacotherapeutic group
Pharmacodynamic properties
Fenbendazole is an anthelmintic belonging to the benzimidazole carbamates group. It acts by interfering in the energy metabolism of the nematode. The anthelmintic efficacy is based on inhibition of the polymerisation of tubulin to microtubuli. The anthelmintic affects both adult and immature stages of gastro-intestinal and respiratory nematodes.
Pharmacokinetic particulars
Fenbendazole is only partly absorbed after oral administration and is then metabolised in the liver. Fenbendazole and its metabolites are distributed throughout the body and high concentrations can be found in the liver. The elimination of fenbendazole and its metabolites occurs primarily via the faeces (>90%) and to a small extent in the urine and milk.
Fenbendazole is metabolised to its sulphoxide, then to sulphone and amines.
Pharmaceutical particulars
Excipients
Sodium methyl hydroxybenzoate
Sodium propyl hydroxybenzoate
Benzyl alcohol
Silica colloidal
Carmellose sodium
Povidone
Sodium citrate dehydrate
Citric Acid
Water purified
Major incompatibilities
None.
Shelf life
3 years.
Special precautions for storage
Do not freeze.
Immediate packaging
Multidose container of 100 ml. Container: Opaque white high density polyethylene. Closure: Foil seal with polyethylene screw cap.
Disposal
Any unused product or waste material should be disposed of in accordance with national requirements.
Marketing Authorisation Holder (if different from distributor)
Marketing Authorisation Number
UK: Vm 01708/4428
Significant changes
Date of the first authorisation or date of renewal
30 December 2002
Date of revision of the text
April 2021
Any other information
For animal treatment only. Keep out of the sight and reach of children.
Legal category
Legal category: NFA-VPS
GTIN
GTIN description:Panacur 2.5% SU 10 x 100 ml:
GTIN:05032984102024